Mobile Microwave-based Diagnosis and Monitoring of Stroke

Summary

This is a prospective, open, multicentre trial that will enrol patients with clinical signs of stroke in the acute phase admitted for CT scan. The study assesses the diagnostic capability and safety of Strokefinder MD100.

Conditions

• Stroke, Acute
• Intracerebral Hemorrhage

Interventions

DIAGNOSTIC_TEST

Hemorrhagic stroke group (group A)

Group A: A microwave measurement (Stroke finder MD100) will be performed with the patient lying on the ambulance stretcher, in the hospital bed or another suitable surface.

DIAGNOSTIC_TEST

Ischemic stroke group (group B)

Group B: A microwave measurement (Stroke finder MD100) will be performed with the patient lying on the ambulance stretcher, in the hospital bed or another suitable surface.

DIAGNOSTIC_TEST

Stroke mimic group (group C)

Group C: A microwave measurement (Stroke finder MD100) will be performed with the patient lying on the ambulance stretcher, in the hospital bed or another suitable surface.

Sponsors & Collaborators

• Haukeland University Hospital

  collaborator OTHER

• Equinor

  collaborator UNKNOWN

• Medfield Diagnostics

  collaborator INDUSTRY

• Nordlandssykehuset HF

  collaborator OTHER

• Helse Stavanger HF

  lead OTHER_GOV

Principal Investigators

• Martin Kurz, PhD · Helse Stavanger HF

Study Design

Allocation

NON_RANDOMIZED

Purpose

DIAGNOSTIC

Masking

NONE

Model

PARALLEL

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2018-02-01

Primary Completion

2022-02-28

Completion

2025-02-28

Countries

• Norway

Study Locations